Tuesday, June 11, 2019

InGeneron Adds $23M To Series D Funding For Rotator Cuff Therapy

Houston-based InGeneron, a developer of regenerative medicine and cell therapy technology, has added $23M in its Series D funding round, the company said this morning

The story you have requested is only available to paid members of the TEXASTECHPULSE web site. Stories newer than 15 days are restricted to paid members only. Please login in order to access this members-only content, or become a member.